From: Metabolic syndrome among psychiatric outpatients with mood and anxiety disorders
Metabolic syndrome | |||
---|---|---|---|
Total sample (n = 229) | Yes (n = 51; 22.3%) | No (n = 178; 77.7%) | |
Waist circumference (cm) | 83.5 ± 10.0 | 94.5 ± 8.5** | 80.4 ± 8.0 |
BMI | 24.2 ± 4.0 | 28.3 ± 3.5** | 23.1 ± 3.3 |
Triglycerides (mg/dL) | 163.7 ± 205.3 | 305.9 ± 349.5** | 122.9 ± 110.9 |
HDL (mg/dL) | 54.1 ± 13.8 | 43.8 ± 9.5** | 57.1 ± 13.4 |
Systolic BP (mmHg) | 118.5 ± 161 | 129.3 ± 15.5** | 115.4 ± 14.9 |
Diastolic BP (mmHg) | 78.1 ± 10.8 | 85.0 ± 10.5** | 76.1 ± 10.1 |
Fasting plasma glucose (mg/dL) | 93.3 ± 19.5 | 107.1 ± 35.3** | 89.4 ± 8.4 |
DS | 13.8 ± 8.2 | 13.2 ± 7.5 | 13.9 ± 8.4 |
SS | 10.2 ± 6.4 | 8.7 ± 4.7* | 10.6 ± 6.7 |
HADS-D | 8.3 ± 4.9 | 9.1 ± 5.3 | 8.1 ± 4.8 |
HADS-A | 9.7 ± 4.7 | 9.0 ± 4.4 | 10.0 ± 4.7 |
HAMD | 11.8 ± 6.9 | 11.7 ± 6.1 | 11.8 ± 7.1 |
Antipsychotics (Yes; %) | 53 (23.1%) | 18 (35.3%)* | 35 (19.7%) |
Mood stabilizers (Yes; %) | 28 (12.2%) | 10 (19.6%) | 18 (10.1%) |
Antidepressants (Yes; %) | 205 (89.5%) | 45 (88.2%) | 160 (89.9%) |
Number of medications | 1.6 ± 0.8 | 1.8 ± 0.8* | 1.5 ± 0.8 |
Medication cost per day (NTD) | 47.8 ± 67.8 | 70.7 ± 87.4* | 41.2 ± 59.7 |
Years of pharmacotherapy | 4.4 ± 4.3 | 5.2 ± 5.1 | 4.1 ± 4.1 |
Self-reported weight gain (kg) | 4.1 ± 6.7 | 7.5 ± 7.7** | 3.1 ± 6.1 |
Age (years) | 44.2 ± 9.9 | 47.3 ± 9.3* | 43.3 ± 10.0 |
Years of education | 11.4 ± 3.2 | 10.5 ± 3.1* | 11.6 ± 3.3 |
Gender (Female) | 144 (62.9%) | 29 (56.9%) | 115 (64.6%) |
Paid employment (Yes) | 139 (60.7%) | 28 (54.9%) | 111 (62.4%) |
Married (Yes) | 160 (69.6%) | 35 (68.6%) | 125 (70.2%) |